TickerFactsScreenerDevelopers

Immuneering Corp (IMRX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2020: $1.28M2021: $1.15M2022: $158.1K2023: $0$0
2020Cost of Revenue (USD)2023
Fiscal YearCost of RevenueChange YoY
2023$0-100.0%
2022$158.1K-86.3%
2021$1.15M-9.9%
2020$1.28M—